+++Journal of Medicinal Chemistry;

[Asa]

1.McClure, Kim F.; Abramov, Yuriy A.; Laird, Ellen R.; Barberia, John T.; Cai, Weiling; Carty, Thomas J.; Cortina, Santo R.; Danley, Dennis E.; Dipesa, Alan J.; Donahue, Kathleen M.; Dombroski, Mark A.; et al.;
Theoretical and Experimental Design of Atypical Kinase Inhibitors: Application to p38 MAP Kinase
Journal of Medicinal Chemistry;
48; 18; 2005; 5728 - 5737

Код: Выделить всё

http://dx.doi.org/10.1021/jm050346q

2.Edmondson, Scott D.; Mastracchio, Anthony; Mathvink, Robert J.;He, Jiafang; Harper, Bart; Park, You-Jung; Beconi, Maria; Salvo, Jerry Di; Eiermann,George J.; He, Huaibing; Leiting, Barbara; et al.;
(2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-a]- pyridin-6-ylphenyl)butanamide: A Selective α-Amino Amide Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
Journal of Medicinal Chemistry;
49; 11; 2006; 3614 - 3627;

Код: Выделить всё

http://dx.doi.org/10.1021/jm060015t

[mlkost]